SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-015185
Filing Date
2024-02-14
Accepted
2024-02-14 16:00:13
Documents
1
Period of Report
2024-02-12

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5854
  Complete submission text file 0000950170-24-015185.txt   7989
Mailing Address C/O FLAGSHIP PIONEERING, INC. 55 CAMBRIDGE PARKWAY, SUITE 800E CAMBRIDGE MA 02142
Business Address
AFEYAN NOUBAR (Reporting) CIK: 0001222012 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39941 | Film No.: 24637309

Mailing Address 55 CAMBRIDGE PARKWAY, SUITE 800E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY, SUITE 800E CAMBRIDGE MA 02142 617 868-1888
Flagship Pioneering Inc. (Reporting) CIK: 0001400240 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-39941 | Film No.: 24637310

Mailing Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Issuer) CIK: 0001770121 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)